Recce Pharmaceuticals Ltd

Recce Pharmaceuticals Ltdverified

RECEF

Price:

$0.22

Market Cap:

$177.85M

Recce Pharmaceuticals Ltd, a biotechnology company, engages in the research, development, and commercialization of synthetic anti–infectives in Australia, the United States, and the United Kingdom. The company's lead candidate is RECCE 327 to treat blood infections and sepsis derived from E. coli and S. aureus bacteria, including their superbug forms. It also develops RECCE 529, a synthetic anti-infective for viral infections; and RECCE 435, a synthetic polymer anti-infective. The company was formerly known as Recce Limited and changed its name to Recce Pharmaceuticals Ltd in November 2017. Recce Pharmaceuticals Ltd was incorporated in 2007 and is headquartered in Sydney, Australia.

Industry

Biotechnology

IPO Date

2022-08-12

Stock Exchange

OTC

Ticker

RECEF

The Enterprise Value as of December 2025 (TTM) for Recce Pharmaceuticals Ltd (RECEF) is 178.17M

According to Recce Pharmaceuticals Ltd’s latest financial reports and current stock price. The company's current Enterprise Value is 178.17M. This represents a change of 79.93% compared to the average of 99.02M of the last 4 quarters.

Recce Pharmaceuticals Ltd (RECEF) Historical Enterprise Value (quarterly & annually)

How has RECEF Enterprise Value performed in the past?

The mean historical Enterprise Value of Recce Pharmaceuticals Ltd over the last ten years is 69.03M. The current 178.17M Enterprise Value has changed 25.71% with respect to the historical average. Over the past ten years (40 quarters), RECEF's Enterprise Value was at its highest in in the June 2022 quarter at 146.60M. The Enterprise Value was at its lowest in in the December 2012 quarter at 0.

Quarterly (TTM)
Annual

Average

69.03M

Median

75.84M

Minimum

10.47M

Maximum

143.47M

Recce Pharmaceuticals Ltd (RECEF) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Recce Pharmaceuticals Ltd Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 300.22%

Maximum Annual Enterprise Value = 143.47M

Minimum Annual Increase = -32.74%

Minimum Annual Enterprise Value = 10.47M

Quarterly (TTM)
Annual
YearEnterprise ValueChange
202569.04M-32.74%
2024102.66M-4.44%
2023107.43M-25.12%
2022143.47M15.91%
2021123.78M49.80%
202082.63M300.22%
201920.65M33.89%
201815.42M4.36%
201714.78M41.11%
201610.47M109.31%

Recce Pharmaceuticals Ltd (RECEF) Average Enterprise Value

How has RECEF Enterprise Value performed in the past?

The current Enterprise Value of Recce Pharmaceuticals Ltd (RECEF) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

93.04M

5-year avg

109.28M

10-year avg

69.03M

Recce Pharmaceuticals Ltd (RECEF) Enterprise Value vs. Peers

How is RECEF’s Enterprise Value compared to its peers?

Recce Pharmaceuticals Ltd’s Enterprise Value is greater than Adocia S.A. (140.62M), less than Faron Pharmaceuticals Oy (243.37M), less than AnGes, Inc. (22.77B), greater than Broncus Holding Corporation (142.65M), greater than EKF Diagnostics Holdings plc (92.49M), less than Eupraxia Pharmaceuticals Inc. (188.99M), less than ACS Global, Inc. (0), less than Prescient Therapeutics Limited (0), greater than Adocia S.A. (140.62M), greater than Planet 13 Holdings Inc. (102.72M),

Build a custom stock screener for Recce Pharmaceuticals Ltd (RECEF) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Recce Pharmaceuticals Ltd using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Recce Pharmaceuticals Ltd (RECEF) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Recce Pharmaceuticals Ltd or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Enterprise Value?

How can you use the Enterprise Value?

What is Recce Pharmaceuticals Ltd's Enterprise Value?

What is the highest Enterprise Value for Recce Pharmaceuticals Ltd (RECEF)?

What is the 3-year average Enterprise Value for Recce Pharmaceuticals Ltd (RECEF)?

What is the 5-year average Enterprise Value for Recce Pharmaceuticals Ltd (RECEF)?

How does the current Enterprise Value for Recce Pharmaceuticals Ltd (RECEF) compare to its historical average?